{
  "ticker": "BOT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975372",
  "id": "02975372",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250731",
  "time": "1521",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250731/pdf/06md1tx7gt1l0q.pdf",
  "summary": "**Key Material Information from Botanix Pharmaceuticals (BOT) ASX Announcement:**  \n\n- **Gross Sales**: ~$25M AUD achieved since January 2025, with monthly growth from January to June 2025.  \n- **Prescription Growth**: 16,000+ prescriptions filled across 6,700 patients from launch to 30 June 2025.  \n- **Patient Adherence**: Auto-refill program patients showed 95% adherence rate; overall adherence at 79%.  \n\n**Other Notes**:  \n- BOT confirmed compliance with ASX Listing Rules regarding disclosure timing (data finalized by 7 July 2025, announced 8 July 2025).  \n- No prior announcements were made as data verification was completed just before release.  \n\n**Price Impact**:  \n- Share price dropped from $0.34 (4 July) to $0.31 (7 July) pre-announcement, then to $0.13 intraday post-announcement (8 July).  \n\n**Conclusion**: Operational metrics (sales, prescriptions, adherence) are material and likely drove price volatility. Disclosure timing deemed compliant.  \n\n*Omitted: Legal boilerplate, ASX correspondence details, and procedural explanations.*",
  "usage": {
    "prompt_tokens": 3135,
    "completion_tokens": 252,
    "total_tokens": 3387,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-31T05:45:21.315918"
}